Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-01003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2020-03-18^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5037f7f823eebd6b82cc13fa26a18143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0d1527a1c9e81c2c5dd1edf7f4e46eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3259914218dd181792dd033e252e75ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8b32f87ddbb6a69356fea013f8d032f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab4ee9a7d256896e89883ef288bc9e5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13fb72886ebd5ee64451f8df89c35812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6dd4b35277f1a55a2085ea81c6d9a9c |
publicationDate |
2020-07-23^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020230064-A1 |
titleOfInvention |
Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency |
abstract |
The present disclosure relates to pharmaceutical compositions comprising enzymes or enzyme mixtures having lipolytic and other optional other activities and methods of use thereof to treat exocrine pancreatic insufficiency. |
priorityDate |
2015-02-04^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |